Acute respiratory distress syndrome is a common complication of severe viral pneumonia,
such as influenza and COVID‐19, that requires critical care including ventilatory support …

Abstract Severe coronavirus disease (COVID-19) is currently managed with systemic
glucocorticoids. Opportunistic fungal infections are of concern in such patients. While COVID …

Therapeutic Advances in Infectious Disease 8 2 journals. sagepub. com/home/tai caring for
patients with COVID-19, the empiric overuse of corticosteroids has been associated with …

Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …

Background A surge in COVID-19-associated mucormycosis cases has been observed
during the second wave of COVID-19 in summer of 2021. Most cases were reported from …

Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

Background The epidemiology of the Coronavirus-disease associated mucormycosis (CAM)
syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden …

Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …

Hospitalized patients with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)
are at risk for developing secondary fungal infections due to greater incidence of preexisting …

Abstract During September–December 2020, we conducted a multicenter retrospective
study across India to evaluate epidemiology and outcomes among cases of coronavirus …